Delayed release pancrelipase for the treatment of pancreatic exocrine insufficiency associated with cystic fibrosis

Pancreatic enzyme replacement therapy (PERT) is the only treatment for malabsorption in cystic fibrosis (CF) caused by pancreatic insufficiency (PI). PI occurs in approximately 85% of patients with CF. PERT overcomes some, but not all the signs and symptoms of malabsorption. Clinical parameters such...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autor: Baker, Susan S
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2008
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2621407/
https://ncbi.nlm.nih.gov/pubmed/19209287
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky